LNCTAC
LIVE

Serial Number

79398894

Owner

Chengdu Lnctac Biotechnology Co., Ltd.

Attorney

Justin Brown

Filing Date

Mar 8, 2024

Add to watchlist:

No watchlists yet
View on USPTO

LNCTAC Trademark

Serial Number: 79398894 • Registration: 7781268

LNCTAC is a trademark filed by Chengdu Lnctac Biotechnology Co., Ltd. on March 8, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Chengdu Lnctac Biotechnology Co., Ltd.

Chengdu Tianfu International Biological City,

Entity Type: 99

Trademark Details

Filing Date

March 8, 2024

Registration Date

May 6, 2025

Published for Opposition

March 18, 2025

Goods & Services

Technological research in the field of computer hardware systems and renewable energy resources; research and analysis of biochemistry; medical research laboratory services; genetic testing for scientific research purposes; medical research; biological research and analysis; stem cell research services; development of pharmaceutical preparations and medicines; scientific research in the nature of conducting clinical trials for others; industrial design

Medicines for human purposes for treatment of oncological diseases, dermatological disorders, respiratory diseases, cardiovascular diseases, and neurodegenerative disorders; reagents for medical purposes; pharmaceutical preparations for the treatment of cancer, skin infections, chronic respiratory conditions, cardiovascular diseases, and neurodegenerative conditions; diagnostic preparations for medical purposes; medicines for veterinary purposes for treatment of infectious diseases, metabolic disorders, and inflammatory conditions in animals; nutraceutical preparations for therapeutic and medical purposes for the treatment of immune deficiencies, metabolic disorders, and inflammatory conditions; dietetic substances adapted for medical use, namely, dietetic foods and beverages adapted for medical use, dietetic preparations adapted for medical purposes; disinfectants; medical dressings; vaccines

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 25, 2025 FINO
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 18, 2025 OPNX
FINAL DISPOSITION NOTICE SENT TO IB
Dec 4, 2025 FICS
FINAL DISPOSITION PROCESSED
Dec 3, 2025 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 3, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 3, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 6, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 6, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
May 6, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 18, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 18, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 12, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 24, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 24, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 24, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 24, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 24, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 20, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 20, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 20, 2025 TROA
REFUSAL PROCESSED BY IB
Oct 12, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 25, 2024 RFCS
REFUSAL PROCESSED BY MPU
Sep 25, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 22, 2024 RFCR
NON-FINAL ACTION WRITTEN
Sep 21, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 20, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 10, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 10, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 4, 2024 REPR